281 related articles for article (PubMed ID: 15562322)
1. A taxpayer-funded clinical trials registry and results database.
Turner EH
PLoS Med; 2004 Dec; 1(3):e60. PubMed ID: 15562322
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials registries: towards improved access to therapeutic data.
Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
[TBL] [Abstract][Full Text] [Related]
3. Few studies reporting results at US government clinical trials site.
Kuehn BM
JAMA; 2012 Feb; 307(7):651-3. PubMed ID: 22337663
[No Abstract] [Full Text] [Related]
4. Full access for government-funded clinical trials.
Meyer MA
Arch Neurol; 2002 Oct; 59(10):1664. PubMed ID: 12374509
[No Abstract] [Full Text] [Related]
5. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
6. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.
Law MR; Kawasumi Y; Morgan SG
Health Aff (Millwood); 2011 Dec; 30(12):2338-45. PubMed ID: 22147862
[TBL] [Abstract][Full Text] [Related]
7. Progress and deficiencies in the registration of clinical trials.
Wood AJ
N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
[No Abstract] [Full Text] [Related]
8. Results of drug trials can mystify doctors through omission: some professional groups demand public listing of all test outcomes.
Meier B
N Y Times Web; 2004 Jul; ():C1, C3. PubMed ID: 15290807
[No Abstract] [Full Text] [Related]
9. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
[TBL] [Abstract][Full Text] [Related]
10. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
11. Clinical trials. Facing criticism, industry offers to share data.
Couzin J
Science; 2005 Jan; 307(5707):189. PubMed ID: 15653471
[No Abstract] [Full Text] [Related]
12. Medicine. A portfolio model of drug development for tuberculosis.
Glickman SW; Rasiel EB; Hamilton CD; Kubataev A; Schulman KA
Science; 2006 Mar; 311(5765):1246-7. PubMed ID: 16513969
[No Abstract] [Full Text] [Related]
13. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
14. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
J Natl Cancer Inst; 2004 Sep; 96(18):1355. PubMed ID: 15367566
[No Abstract] [Full Text] [Related]
15. Public registration of clinical trials.
Steinbrook R
N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
[No Abstract] [Full Text] [Related]
16. Europe. Drug watchdog ponders how to open clinical trial data vault.
Rabesandratana T
Science; 2013 Mar; 339(6126):1369-70. PubMed ID: 23520086
[No Abstract] [Full Text] [Related]
17. European drug agency under fire: critics charge that trial data are too inaccessible.
Hampton T
JAMA; 2011 Aug; 306(6):593-5. PubMed ID: 21828315
[No Abstract] [Full Text] [Related]
18. Publication rates of registered clinical trials in macular degeneration.
Prenner JL; Driscoll SJ; Fine HF; Salz DA; Roth DB
Retina; 2011 Feb; 31(2):401-4. PubMed ID: 21221049
[TBL] [Abstract][Full Text] [Related]
19. Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
[No Abstract] [Full Text] [Related]
20. The old file-drawer problem.
Kennedy D
Science; 2004 Jul; 305(5683):451. PubMed ID: 15273363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
